Simplex Trading’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,800
Closed -$867K 10210
2024
Q1
$867K Buy
24,800
+19,400
+359% +$707K ﹤0.01% 3270
2023
Q4
$205K Buy
5,400
+4,600
+575% +$98.6K ﹤0.01% 4665
2023
Q3
$14K Hold
800
﹤0.01% 6963
2023
Q2
$20K Buy
800
+700
+700% +$16.3K ﹤0.01% 6809
2023
Q1
$1K Hold
100
﹤0.01% 8866
2022
Q4
$2K Sell
100
-7,900
-99% -$232K ﹤0.01% 8735
2022
Q3
$143K Buy
8,000
+7,900
+7,900% +$142K ﹤0.01% 5041
2022
Q2
$1K Hold
100
﹤0.01% 9801
2022
Q1
$2K Buy
+100
New +$2.55K ﹤0.01% 10014

Other funds holding INBX

Simplex Trading's INBX Position: Q2 2024 in Review

Simplex Trading sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 1,215 shares — an estimated $42K sold.

Simplex Trading first reported a position in INBX in Q4 2021 and held it in 6 quarters. The position peaked at $1.36M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Simplex Trading reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 1,215 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $42K.
  • Simplex Trading first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Simplex Trading's Inhibrx, Inc. Common Stock position peaked at $1.36M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.